Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 46

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury

George, Nayana, Chen, Minjun, Yuen, Nancy, Hunt, Christine M., Suzuki, Ayako · 2018 · Regulatory Toxicology and Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yrtph.2018.01.018

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 32

  1. Anderson, 2005, Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics, J Womens Health (Larchmt), 14, 19, 10.1089/jwh.2005.14.19 · DOI · Paper page
  2. Andrade, 2005, Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
  3. Boelsterli, 2007, Mitochondrial abnormalities–a link to idiosyncratic drug hepatotoxicity?, Toxicol. Appl. Pharmacol., 220, 92, 10.1016/j.taap.2006.12.013 · DOI · Paper page
  4. Chen, 2013, High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury, Hepatology, 58, 388, 10.1002/hep.26208 · DOI · Paper page
  5. Chen, 2015, Drug-Induced liver injury: interactions between drug properties and host factors, J. Hepatol., 63, 503, 10.1016/j.jhep.2015.04.016 · DOI · Paper page
  6. Chen, 2013, The liver toxicity knowledge base: a systems approach to a complex end point, Clin. Pharmacol. Ther., 93, 409, 10.1038/clpt.2013.16 · DOI
  7. Cho, 2013, Sex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for Tregs, estrogen, and IL-6, PLoS One, 8, 10.1371/journal.pone.0061186 · DOI
  8. de Lima Toccafondo Vieira, 2014, Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools, Expet Opin. Drug Metabol. Toxicol., 10, 581, 10.1517/17425255.2014.884069 · DOI
  9. De Valle, 2006, Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic, Aliment. Pharmacol. Ther., 24, 1187, 10.1111/j.1365-2036.2006.03117.x · DOI · Paper page
  10. deLemos, 2016, Amoxicillin-clavulanate-induced liver injury, Dig. Dis. Sci., 61, 2406, 10.1007/s10620-016-4121-6 · DOI
  11. DuMouchel, 1999, Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System (with discussion), Am. Statistician, 53, 177, 10.1080/00031305.1999.10474456 · DOI · Paper page
  12. Fontana, 2013, Presentation and outcomes with clinically apparent interferon beta hepatotoxicity, Dig. Dis. Sci., 58, 1766, 10.1007/s10620-012-2553-1 · DOI
  13. Fontana, 2014, Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset, Gastroenterology, 147, 10.1053/j.gastro.2014.03.045 · DOI · Paper page
  14. Hunt, 1992, Effect of age and gender on the activity of human hepatic CYP3A, Biochem. Pharmacol., 44, 275, 10.1016/0006-2952(92)90010-G · DOI · Paper page
  15. Hunt, 2014, Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database, Regul. Toxicol. Pharmacol., 70, 519, 10.1016/j.yrtph.2014.09.007 · DOI
  16. Knowles, 2000, Idiosyncratic drug reactions: the reactive metabolite syndromes, Lancet, 356, 1587, 10.1016/S0140-6736(00)03137-8 · DOI · Paper page
  17. Lammert, 2010, Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events, Hepatology, 51, 615, 10.1002/hep.23317 · DOI · Paper page
  18. Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
  19. Lucena, 2009, Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex, Hepatology, 49, 2001, 10.1002/hep.22895 · DOI · Paper page
  20. Medina-Caliz, 2016, Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury, J. Hepatol., 65, 532, 10.1016/j.jhep.2016.05.003 · DOI · Paper page
  21. Nichols, 2006, From menarche to menopause: trends among US Women born from 1912 to 1969, Am. J. Epidemiol., 164, 1003, 10.1093/aje/kwj282 · DOI · Paper page
  22. Pauli-Magnus, 2006, Hepatobiliary transporters and drug-induced cholestasis, Hepatology, 44, 778, 10.1002/hep.21359 · DOI · Paper page
  23. Russmann, 2010, Pharmacogenetics of drug-induced liver injury, Hepatology, 52, 748, 10.1002/hep.23720 · DOI
  24. Russo, 2004, Liver transplantation for acute liver failure from drug induced liver injury in the United States, Liver Transplant., 10, 1018, 10.1002/lt.20204 · DOI · Paper page
  25. Schwartz, 2007, The current state of knowledge on age, sex, and their interactions on clinical pharmacology, Clin. Pharmacol. Ther., 82, 87, 10.1038/sj.clpt.6100226 · DOI · Paper page
  26. Sgro, 2002, Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page
  27. Shin, 2013, Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data, Pharmacoepidemiol. Drug Saf., 22, 190, 10.1002/pds.3388 · DOI · Paper page
  28. Suzuki, 2010, Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work, Drug Saf., 33, 503, 10.2165/11535340-000000000-00000 · DOI · Paper page
  29. Suzuki, 2017, Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury, Liver Int., 37, 1723, 10.1111/liv.13380 · DOI
  30. Suzuki, 2015, Comedications alter drug-induced liver injury reporting frequency: data mining in the WHO VigiBase, Regul. Toxicol. Pharmacol., 72, 481, 10.1016/j.yrtph.2015.05.004 · DOI · Paper page
  31. Urban, 2017, Minocycline hepatotoxicity: clinical characterization and identification of HLA-B *35:02 as a risk factor, J. Hepatol., 67, 137, 10.1016/j.jhep.2017.03.010 · DOI · Paper page
  32. Wynne, 2005, Drug metabolism and ageing, J. Br. Menopause Soc., 11, 51, 10.1258/136218005775544589 · DOI

Cited by

See all 46

Metadata

Authors
George, N., Chen, M., Yuen, N., Hunt, C. M., & Suzuki, A.
Venue
Regulatory Toxicology and Pharmacology
Publisher
Elsevier BV
Published
2018-04
Volume
94
Pages
101-107
ISSN
0273-2300
Cited by
46
References
7
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. https://app.cochat.ai/papers/10.1016/j.yrtph.2018.01.018
The paper
George, N., Chen, M., Yuen, N., Hunt, C. M., & Suzuki, A. (2018). Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2018.01.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.